| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Address all correspondence and requests for reprints to: Dr. Emilia Mira, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Spanish Research Council CSIC, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain. E-mail: emira{at}cnb.uam.es
MCF-7 cells migrate through vitronectin-coated filters in response to
insulin-like growth factor I (IGF-I); migration is inhibited by the
matrix metalloproteinase (MMP) inhibitor BB-94, but not by the serine
proteinase inhibitor aprotinin. MMP-9 was identified in the conditioned
medium of MCF-7 cells; in addition, fluorescence-activated cell sorting
analysis revealed its presence on the cell surface, where MMP-9
activity was also found using a specific fluorogenic peptide.
Furthermore, the messenger RNA encoding MMP-9 was detected in MCF-7
cells by PCR. The IGF-I concentration leading to maximal MCF-7 invasion
produces an increase in cell surface proteolytic activity after short
incubation periods. At 18 h, however, preincubation of MCF-7 cells
with IGF-I produces at 18 h a dose-dependent decrease in
cell-associated MMP-9 activity and an increase in soluble MMP-9. MCF-7
invasion is dependent on the
vß5 integrin,
a vitronectin receptor. The levels of
v- and
ß5-subunits expressed in MCF-7 cells depend on the IGF-I
concentration, which triggers an increase in both of these subunits.
Based on these results, we suggest that IGF-I-induced MCF-7 cell
migration is mediated by the MMP-9 activity on the cell surface and by
vß5 integrin.
This article has been cited by other articles:
![]() |
Y. Koyama, H. Naruo, Y. Yoshitomi, S. Munesue, S. Kiyono, Y. Kusano, K. Hashimoto, T. Yokoi, H. Nakanishi, S. Shimizu, et al. Matrix Metalloproteinase-9 Associated with Heparan Sulphate Chains of GPI-Anchored Cell Surface Proteoglycans Mediates Motility of Murine Colon Adenocarcinoma Cells J. Biochem., May 1, 2008; 143(5): 581 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Radjabi, K. Sawada, S. Jagadeeswaran, A. Eichbichler, H. A. Kenny, A. Montag, K. Bruno, and E. Lengyel Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and {beta}1-Integrin on the Cell Surface J. Biol. Chem., February 1, 2008; 283(5): 2822 - 2834. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights Endocr. Rev., February 1, 2007; 28(1): 20 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hirota, Y. Osuga, K. Koga, O. Yoshino, T. Hirata, C. Morimoto, M. Harada, Y. Takemura, E. Nose, T. Yano, et al. The Expression and Possible Roles of Chemokine CXCL11 and Its Receptor CXCR3 in the Human Endometrium J. Immunol., December 15, 2006; 177(12): 8813 - 8821. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chetty, P. Bhoopathi, P. Joseph, S. Chittivelu, J. S. Rao, and S. Lakka Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol. Cancer Ther., September 1, 2006; 5(9): 2289 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-r. Zhao, W. Qiu, Y.-x. Li, Z.-b. Zhang, D. Li, and Y.-l. Wang Dual effect of transforming growth factor {beta}1 on cell adhesion and invasion in human placenta trophoblast cells. Reproduction, August 1, 2006; 132(2): 333 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Dechow, L. Pedranzini, A. Leitch, K. Leslie, W. L. Gerald, I. Linkov, and J. F. Bromberg Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C PNAS, July 20, 2004; 101(29): 10602 - 10607. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mira, R. A. Lacalle, J. M. Buesa, G. G. de Buitrago, S. Jimenez-Baranda, C. Gomez-Mouton, C. Martinez-A, and S. Manes Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface J. Cell Sci., May 1, 2004; 117(9): 1847 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sadowski, S. Dietrich, F. Koschinsky, and R. Sedlacek Matrix Metalloproteinase 19 Regulates Insulin-like Growth Factor-mediated Proliferation, Migration, and Adhesion in Human Keratinocytes through Proteolysis of Insulin-like Growth Factor Binding Protein-3 Mol. Biol. Cell, November 1, 2003; 14(11): 4569 - 4580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass Angiogenesis in Endocrine Tumors Endocr. Rev., October 1, 2003; 24(5): 600 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kabir-Salmani, S. Shiokawa, Y. Akimoto, K. Sakai, S. Nagamatsu, K. Sakai, Y. Nakamura, A. Lotfi, H. Kawakami, and M. Iwashita {alpha}v{beta}3 Integrin Signaling Pathway Is Involved in Insulin-Like Growth Factor I-Stimulated Human Extravillous Trophoblast Cell Migration Endocrinology, April 1, 2003; 144(4): 1620 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Solomon, M. Grueterich, D.-Q. Li, D. Meller, S.-B. Lee, and S. C. G. Tseng Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body Fibroblasts Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 573 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Seki, M. A. Suico, A. Uto, A. Hisatsune, T. Shuto, Y. Isohama, and H. Kai The ETS Transcription Factor MEF Is a Candidate Tumor Suppressor Gene on the X Chromosome Cancer Res., November 15, 2002; 62(22): 6579 - 6586. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Binder, Th. Hagemann, B. Husen, M. Schulz, and A. Einspanier Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases Mol. Hum. Reprod., September 1, 2002; 8(9): 789 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Buckley, A. Cheng, P. A. Kiely, M. L. Tremblay, and R. O'Connor Regulation of Insulin-Like Growth Factor Type I (IGF-I) Receptor Kinase Activity by Protein Tyrosine Phosphatase 1B (PTP-1B) and Enhanced IGF-I-Mediated Suppression of Apoptosis and Motility in PTP-1B-Deficient Fibroblasts Mol. Cell. Biol., April 1, 2002; 22(7): 1998 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Guvakova, J. C. Adams, and D. Boettiger Functional role of {alpha}-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells J. Cell Sci., January 11, 2002; 115(21): 4149 - 4165. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Satyamoorthy, G. Li, B. Vaidya, D. Patel, and M. Herlyn Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and {beta}-Catenin Pathways Cancer Res., October 1, 2001; 61(19): 7318 - 7324. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lu, G. Jiang, P. Blume-Jensen, and T. Hunter Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase Mol. Cell. Biol., June 15, 2001; 21(12): 4016 - 4031. [Abstract] [Full Text] |
||||
![]() |
M. Hidalgo and S. G. Eckhardt Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy J Natl Cancer Inst, February 7, 2001; 93(3): 178 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Dunn, J. V. Torres, J. S. Oh, D. M. Cykert, and J. C. Barrett Up-Regulation of Urokinase-Type Plasminogen Activator by Insulin-like Growth Factor-I Depends upon Phosphatidylinositol-3 Kinase and Mitogen-activated Protein Kinase Kinase Cancer Res., February 1, 2001; 61(4): 1367 - 1374. [Abstract] [Full Text] |
||||
![]() |
M. E. Kupferman, M. E. Fini, W. J. Muller, R. Weber, Y. Cheng, and R. J. Muschel Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor Progression Am. J. Pathol., December 1, 2000; 157(6): 1777 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Conover, L. K. Bale, S. K. Durham, and D. R. Powell Insulin-Like Growth Factor (IGF) Binding Protein-3 Potentiation of IGF Action Is Mediated through the Phosphatidylinositol-3-Kinase Pathway and Is Associated with Alteration in Protein Kinase B/AKT Sensitivity Endocrinology, September 1, 2000; 141(9): 3098 - 3103. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |